The public pharmaceutical industrial complex, Sidal, supervised the signing of a cooperation agreement with the leading German company in research and development of biopharmaceuticals, Bohringer Ingelheim, with the aim of localizing the manufacture and production of an innovative treatment for pulmonary fibrosis in the Algerian market. The signing ceremony was supervised by the Minister of Pharmaceutical Industry, Wassim Qwaidry. The Ambassador of the Federal Republic of Germany to Algeria, Georg […] The post, in cooperation with Germany...signing an agreement to manufacture and produce an innovative treatment for pulmonary fibrosis appeared first on Al-Nahar Online.